Calcitonin ameliorates enhanced arterial contractility after chronic constriction injury of the sciatic nerve in rats

Fundamental and Clinical Pharmacology

Volumn 26, Issue 3, 2012, Pages 315-321

  Yoshimura, Takeshi ^a,b   Ito, Akitoshi ^a   Saito, Shin Ya ^b   Takeda, Mineko ^a   Kuriyama, Hiroshi ^a   Ishikawa, Tomohisa ^b  

^a ASAHI KASEI PHARMA CORPORATION   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Calcitonin; CCI; Noradrenaline; Peripheral circulatory disturbance; Plantar artery; Vasodilation

Indexed keywords

ELCATONIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DRUG EFFECT; LASER DOPPLER FLOWMETRY; MALE; NERVE INJURY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SKIN BLOOD FLOW;

ANIMALS; ARTERIES; BLOOD FLOW VELOCITY; CALCITONIN; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; EELS; FISH PROTEINS; HINDLIMB; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SKIN; VASOCONSTRICTION;

EID: 84860233487     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.00934.x     Document Type: Article

References (38)

1. Munson P.L. Physiology and pharmacology of thyrocalciotonin, in: Aurbach G.D. (Ed.), Handbook of physiology, vol. 7, American Physiological Society, Washington DC, USA, 1976, pp. 443-464.
2. Potts J.T. Jr, Aurbach G.D. Chemistry in calcitonin, in: Aurbach G.D. (Ed.), Handbook of physiology, vol. 7, American Physiological Society, Washington DC, USA, 1976, pp. 423-430.
3. Nicholson G.C., Moseley J.M., Sexton P.M., Mendelsohn F.A., Martin T.J. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J. Clin. Invest. (1986) 78 355-360.
4. Suzuki H., Nakamura I., Takahashi N. et al. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology (1996) 137 4685-4690.
5. Silva O.L., Becker K.L. Salmon calcitonin in the treatment of hypercalcemia. Arch. Intern. Med. (1973) 132 337-339.
6. Orimo H., Morii H., Inoue T. et al. Effect of elcatonin on involutional osteoporosis. J. Bone Miner. Metab. (1996) 14 73-78.
7. Jiménez F.E., Albizuri J.M.A., Alier J.M.A., Soto J.J.M., Canales A.G. Effectiveness and safety of medium- and long-term elcatonin use in the prevention and treatment of bone mass loss. Curr. Ther. Res. (1995) 56 385-399.
8. Reginster J.Y., Denis D., Deroisy R. et al. Long-term (3years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin. J. Bone Miner. Res. (1994) 9 69-73.
9. Pontiroli A.E., Pajetta E., Scaglia L. et al. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study. Aging (Milano) (1994) 6 459-463.
10. Aida S., Shimoji K. Effects of calcitonin on rheumatoid arthritis and the relation with corticosteroids. Pain Res. (1990) 5 85-91.
11. Blanchard J., Menk E., Ramamurthy S., Hoffman J. Subarachnoid and epidural calcitonin in patients with pain due to metastatic cancer. J. Pain Symptom Manage. (1990) 5 42-45.
12. Perez R.S., Kwakkel G., Zuurmond W.W., de Lange J.J. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J. Pain Symptom Manage. (2001) 21 511-526.
13. Manicourt D.H., Azria M., Mindeholm L., Thonar E.J., Devogelaer J.P. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum. (2006) 54 3205-3211.
14. Takayama B., Kikuchi S., Konno S., Sekiguchi M. An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats. BMC Musculoskelet. Disord. (2008) 15 164.
15. Ito A., Kumamoto E., Takeda M., Shibata K., Sagai H., Yoshimura M. Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J. Neurosci. (2000) 20 6302-6308.
16. Shibata K., Takeda M., Ito A., Takeda M., Sagai H. Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin. Pharmacol. Biochem. Behav. (1998) 60 371-376.
17. Franchi F., Chiarini P., Matassi L. et al. Effects of calcitonin on limb blood vessels in human obstructive arterial disease. Int. J. Clin. Pharmacol. Res. (1983) 3 115-128.
18. Ide J., Yamaga M., Kitamura T., Takagi K. Quantitative evaluation of sympathetic nervous system dysfunction in patients with reflex sympathetic dystrophy. J. Hand Surg. Br. (1997) 22 102-106.
19. Herrick A.L. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) (2005) 44 587-596.
20. Flavahan N.A., Flavahan S., Liu Q. et al. Increased α2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum. (2000) 43 1886-1890.
21. Birklein F., Riedl B., Claus D., Neundörfer B., Handwerker H.O. Cutaneous norepinephrine application in complex regional pain syndrome. Eur. J. Pain (1997) 1 123-132.
22. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 33 87-107.
23. Kurvers H.A., Tangelder G.J., de Mey J.G. et al. Skin blood flow abnormalities in a rat model of neuropathic pain: result of decreased sympathetic vasoconstrictor outflow? J. Auton. Nerv. Syst. (1997) 63 19-29.
24. Kurvers H., Daemen M., Slaaf D. et al. Partial peripheral neuropathy and denervation induced adrenoceptor supersensitivity. Functional studies in an experimental model. Acta Orthop. Belg. (1998) 64 64-70.
25. Koganezawa T., Ishikawa T., Fujita Y. et al. Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats. Br. J. Pharmacol. (2006) 148 579-586.
26. Swett J.E., Woolf C.J. The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord. J. Comp. Neurol. (1985) 231 66-77.
27. Carlton S.M., Dougherty P.M., Pover C.M., Coggeshall R.E. Neuroma formation and numbers of axons in a rat model of experimental peripheral neuropathy. Neurosci. Lett. (1991) 131 88-92.
28. Couture R., Gaudreau P., St-Pierre S., Regoli D. The dog common carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins. Can. J. Physiol. Pharmacol. (1980) 58 1234-1244.
29. Moura A.M., Janiak P., Robert A.M., Robert L., Worcel M. Ex vivo and in vivo effects of calcitonin on vascular smooth muscle permeability to Ca2+. Colloq. INSERM/CNRS (1984) 124 489-494.
30. Schleiffer R., Helwig J.J., Pernot F., Gairard A. Vascular effects of calcitonin and parathyroid hormone, in: Doepfner W. (Ed.), Calcitonin 1984, Excerpta Medica, Amsterdam, Netherlands, 1986, pp. 15-24.
31. Bukoski R.D., Ishibashi K., Bian K. Vascular actions of the calcium-regulating hormones. Semin. Nephrol. (1995) 15 536-549.
32. Ogawa K., Hori M., Takao R., Sakurada T. Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats. J. Bone Miner. Metab. (2005) 23 351-358.
33. Aikawa R., Ohyama K., Mori E., Hironaka K., Miyake M., Morishita M. Enzyme immunoassay for elcatonin, a synthetic analogue of eel calcitonin, in plasma. J. Pharm. Sci. (1985) 74 300-303.
34. Hilton J.M., Dowton M., Houssami S., Sexton P.M. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J. Endocrinol. (2000) 66 213-226.
35. Koenigsberger M., Sauser R., Seppey D., Bény J.L., Meister J.J. Calcium dynamics and vasomotion in arteries subject to isometric, isobaric, and isotonic conditions. Biophys. J. (2008) 95 2728-2738.
36. Tankó L.B., Mikkelsen E.O., Frøbert O., Bagger J.P., Gregersen H. A new method for combined isometric and isobaric pharmacodynamic studies on porcine coronary arteries. Clin. Exp. Pharmacol. Physiol. (1998) 25 919-927.
37. VanBavel E., Mulvany M.J. Role of wall tension in the vasoconstrictor response of cannulated rat mesenteric small arteries. J. Physiol. (1994) 477 103-115.
38. Wookey P.J., Zulli A., Hare D.L. The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque. Histochem. Cell Biol. (2009) 132 181-189.